Pharmacist care plans and documentation of follow-up before the Iowa Pharmaceutical Case Management program

Journal of the American Pharmacists Association

Volumn 44, Issue 3, 2004, Pages 350-357

  Becker, CoraLynn ^a   Bjornson, Darrel C ^b   Kuhle, Julie W ^c  

^a UNIVERSITY OF KANSAS MEDICAL CENTER   (United States)

^b DRAKE UNIVERSITY   (United States)

^c Iowa Hospital Association   (United States)

Author keywords

Continuity of care; Documentation; Drug therapy problems; Monitoring; Outcomes; Patient follow up; Pharmaceutical care

Indexed keywords

ARTICLE; CASE MANAGEMENT; CROSS-SECTIONAL STUDY; DOCUMENTATION; DRUG THERAPY; FEMALE; FOLLOW UP; HUMAN; MALE; MIDDLE AGED; PHARMACY; STANDARD; UNITED STATES;

CASE MANAGEMENT; CROSS-SECTIONAL STUDIES; DOCUMENTATION; DRUG THERAPY; FEMALE; FOLLOW-UP STUDIES; HUMANS; IOWA; MALE; MIDDLE AGED; PHARMACY;

EID: 2942718945     PISSN: 15443191     EISSN: 15443450     Source Type: Journal    
DOI: 10.1331/154434504323063986     Document Type: Article

References (16)

1. Hepler CD, Strand LM. Opportunities and responsibilities in pharmaceutical care. Am J Hosp Pharm. 1990;47:533-43.
2. Posey LM. Pharmaceutical care: will pharmacy incorporate its philosophy of practice? J Am Pharm Assoc. 1997;NS37:145-8.
3. Rovers JP, Currie JD, Hagel HP, et al. Patient care plan development. In: A practical guide to pharmaceutical care. Washington, D.C.: American Pharmaceutical Association; 1998:77-102.
4. English T. Iowa Medicaid patients benefit from pharmacists' services. Pharm Today. 2000;6(11):1.
5. Currie JD, Doucette WR, Kuhle J, et al. Identification of essential elements in the documentation of pharmacist-provided care. J Am Pharm Assoc. 2003;43:41-9.
6. Tomechko MA, Strand LM, Morley PC, et al. Q and A from the pharmaceutical care project in Minnesota. Am Pharm.1995;NS35:30-9.
7. Foisy MM, Tseng A, Blaikie N. Pharmacists' provision of continuity of care to patients with human immunodeficiency virus infection. Am J Health Syst Pharm. 1996;53:1013-7.
8. Dvorak SR, McCoy RA, Voss GD. Continuity of care from acute to ambulatory care setting. Am J Health Syst Pharm. 1998;55:2500-4.
9. Nichols-English G, Poirier S. Optimizing adherence to pharmaceutical care plans. J Am Pharm Assoc. 2000;40:475-85.
10. McDonough RP. Interventions to improve patient pharmaceutical care outcomes. J Am Pharm Assoc. 1996;NS36:453-65.
11. Westerlund T, Almarsdottir AB, Melander A. Factors influencing the detection rate of drug-related problems in community pharmacy. Pharm World Sci. 1999;21:245-50.
12. Rich DS. Pharmaceutical care plans. Hosp Pharm. 1994;29:176-81.
13. Currie JD, Chrischilles EA, Kuehl AK, et al. Effect of a training program on community pharmacists' detection of and intervention in drug-related problems. J Am Pharm Assoc. 1997;NS37:182-91.
14. Briceland LL, Kane MP, Hamilton RA. Evaluation of patient-care interventions by PharmD clerkship students. Am J Hosp Pharm. 1992;49:1130-2.
15. Westerholm T, Almarsdottir AB, Melander AB. Drug-related problems and pharmacy interventions in community practice. Int J Pharm Pract. 1999;7:40-50.
16. Carter BL, Helling DK. Ambulatory care pharmacy services: has the agenda changed? Ann Pharmacother. 2000;34:772-87.